Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: Results from efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) program
- 1 May 2010
- journal article
- research article
- Published by Elsevier BV in American Heart Journal
- Vol. 159 (5), 841-849.e1
- https://doi.org/10.1016/j.ahj.2010.02.023
Abstract
No abstract availableFunding Information
- Otsuka Pharmaceutical
This publication has 22 references indexed in Scilit:
- Acute Heart Failure SyndromesJournal of the American College of Cardiology, 2009
- Heart Failure-Related Hospitalization in the U.S., 1979 to 2004Journal of the American College of Cardiology, 2008
- Effect of carvedilol and metoprolol on the mode of death in patients with heart failureEuropean Journal of Heart Failure, 2007
- Prediction of Mode of Death in Heart FailureCirculation, 2007
- Acute Heart Failure SyndromesCirculation, 2005
- Mode of Death in Advanced Heart Failure: The Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) TrialJournal of the American College of Cardiology, 2005
- Mode of death in heart failure: findings from the ATLAS trialHeart, 2003
- Effect of amlodipine on mode of death among patients with advanced heart failure in the praise trialThe American Journal of Cardiology, 1998
- Influence of concomitant disease on patterns of hospitalization in patients with heart failure discharged from Scottish hospitals in 1995.European Heart Journal, 1998
- The Treatment of Unrelated Disorders in Patients with Chronic Medical DiseasesThe New England Journal of Medicine, 1998